These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3552512)

  • 21. Induction of beta-cell rest in type 1 diabetes. Studies on the effects of octreotide and diazoxide.
    Björk E; Berne C; Karlsson FA
    Diabetes Care; 1998 Mar; 21(3):427-30. PubMed ID: 9540027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of predictors of beta-cell survival in type I diabetes.
    Schiffrin A; Suissa S; Poussier P; Guttmann R; Weitzner G
    Diabetes; 1988 Jul; 37(7):920-5. PubMed ID: 3290010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
    Rachman J; Payne MJ; Levy JC; Barrow BA; Holman RR; Turner RC
    Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".
    Banerji MA
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():493-501. PubMed ID: 12017222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
    Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Jos J; Boitard C; Assan R; Robert JJ
    Diabetes Care; 1995 Nov; 18(11):1487-90. PubMed ID: 8722075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assay of C-peptide in diabetes in children and adolescents].
    Jos J; Kestenbaum S
    Ann Med Interne (Paris); 1984; 135(6):416-9. PubMed ID: 6391322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of residual β cell function in long-standing type 1 diabetes.
    Sherr JL; Ghazi T; Wurtz A; Rink L; Herold KC
    Diabetes Metab Res Rev; 2014 Feb; 30(2):154-62. PubMed ID: 24115337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual beta-cell function and metabolic stability in insulin-dependent diabetes mellitus.
    Nakamura H; Takagi A; Tsuda A; Momotsu T; Ito S; Shibata A
    Tohoku J Exp Med; 1988 May; 155(1):71-80. PubMed ID: 3046059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.
    Bonfanti R; Bazzigaluppi E; Calori G; Riva MC; Viscardi M; Bognetti E; Meschi F; Bosi E; Chiumello G; Bonifacio E
    Diabet Med; 1998 Oct; 15(10):844-50. PubMed ID: 9796885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free fatty acids level may effect a residual insulin secretion in type 1 diabetes.
    Zmysłowska A; Wyka K; Szadkowska A; Mianowska B; Pietrzak I; Młynarski W
    Pediatr Endocrinol Diabetes Metab; 2011; 17(1):26-9. PubMed ID: 21489353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of glycosylated haemoglobin to C-peptide secretory status and antibody binding of insulin in insulin-dependent diabetes.
    Gray RS; Borsey DQ; Kurtz A; Rainbow S; Smith AF; Elton RA; Duncan LJ; Clarke BF
    Horm Metab Res; 1981 Nov; 13(11):599-603. PubMed ID: 7030898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.
    Sjöberg S; Ahrén B; Bolinder J
    J Intern Med; 2002 Oct; 252(4):342-51. PubMed ID: 12366607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of bacille Calmette-Guérin vaccination on C-peptide secretion in children newly diagnosed with IDDM.
    Elliott JF; Marlin KL; Couch RM
    Diabetes Care; 1998 Oct; 21(10):1691-3. PubMed ID: 9773732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homogeneity in pattern of decline of beta-cell function in IDDM. Prospective study of 204 consecutive cases followed for 7.4 yr.
    Snorgaard O; Lassen LH; Binder C
    Diabetes Care; 1992 Aug; 15(8):1009-13. PubMed ID: 1505301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
    Vilsbøll T; Toft-Nielsen MB; Krarup T; Madsbad S; Dinesen B; Holst JJ
    Diabetes Care; 2000 Jun; 23(6):807-12. PubMed ID: 10841001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus.
    Montaña E; Fernandez-Castañer M; Rosel P; Gomez J; Soler J
    Diabete Metab; 1991; 17(5):460-8. PubMed ID: 1752347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus.
    Umpaichitra V; Bastian W; Taha D; Banerji MA; AvRuskin TW; Castells S
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1605-9. PubMed ID: 11297591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes.
    Fernandez Castañer M; Montaña E; Camps I; Biarnes J; Merino JF; Escriba JM; Nacher V; Rosel P; Soler J
    Diabetes Metab; 1996 Oct; 22(5):349-55. PubMed ID: 8896997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features.
    Bonora E; Coscelli C; Butturini U
    Acta Diabetol Lat; 1984; 21(4):375-83. PubMed ID: 6397028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.